Table 1. Correlation between ZYG11A mRNA expression and clinicopathologic characteristic.
| Characteristics | Numbers of Patients | Percentage | Fold Change | p-Value |
|---|---|---|---|---|
| Age(years) | 0.096 | |||
| <60 | 19 | 30.20% | 6.1 | |
| >60 | 44 | 69.80% | 9.9 | |
| Sex | 0.269 | |||
| Male | 55 | 87.30% | 9 | |
| Female | 8 | 12.70% | 6.8 | |
| Tumor grade | 0.752 | |||
| High | 1 | 1.60% | 11.6 | |
| Middle | 52 | 82.50% | 8.4 | |
| Low | 10 | 15.90% | 10.2 | |
| Lymph node metastasis | 0.091 | |||
| N0 | 42 | 66.70% | 7.2 | |
| N1 | 7 | 11.10% | 11.1 | |
| N2 | 14 | 22.20% | 12 | |
| Primary Tumor | 0.016* | |||
| T1 | 14 | 22.20% | 5.9 | |
| T2 | 36 | 57.20% | 8 | |
| T3 | 13 | 20.60% | 13.9 | |
| TNM stage | 0.014* | |||
| I | 19 | 30.20% | 6 | |
| II | 28 | 44.40% | 8 | |
| III | 16 | 25.40% | 13.3 | |
| Cancer Type | 0.542 | |||
| Squamous Carcinoma | 13 | 20.60% | 8.5 | |
| Adenocarcinoma | 50 | 79.40% | 8.4 |
*
Significant correlation